icer tirzepatide FDA says years-long shortage is resolved, will give limited leeway to compounders Weight-loss drugs becoming better value

From a clinical perspective, recent data from the TAILORx and MINDACT trials have reaffirmed the central role of endocrine therapies like tamoxifen in reducing recurrence risk, particularly when chemotherapy may be safely avoided in genomically low-risk, ER+ tumors

Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice

If you are prediabetic or have metabolic syndrome, berberine supplementation (at adequate doses) may provide some benefit, though you could get the same ingredient for much less

BMC Medicine, 23(4), Article 4200

When Should You Be More Careful

Some groups argue the GIP arm does real independent work